Literature DB >> 24486367

Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease.

Kazuyo Tamura1, Kousaku Matsubara2, Naruhiko Ishiwada3, Junichiro Nishi4, Hidenori Ohnishi5, Shigeru Suga6, Toshiaki Ihara6, Bin Chang7, Yukihiro Akeda8, Kazunori Oishi9.   

Abstract

Antibody responses to the infecting serotype in children who are vaccinated with pneumococcal conjugate vaccine (PCV) after having invasive pneumococcal diseases (IPD) have not been fully investigated. Of 56 children diagnosed with IPD between October 2009 and April 2013 in whom the infecting serotype was confirmed, 17 who were vaccinated with PCV7 following IPD were tested to determine the geometric mean concentration of serotype-specific immunoglobulin G (IgG) and the geometric mean titers of opsonization indices (OIs) using paired sera obtained at the onset of IPD and after PCV doses following the resolution of IPD. The geometric mean concentrations of serotype-specific IgG for all PCV7 serotypes other than serotype 6B were significantly increased after the last PCV7 dose compared with those at the time of IPD onset (P<0.01), as were the geometric mean titers of OIs for all PCV7 serotypes. In 14 children with IPD caused by PCV7 serotypes for whom both IgG and OI results were available, the OIs for the infecting serotype at the time of IPD onset were <8, although the IgG levels varied between from <0.2 to >5.0μg/ml. After the last PCV7 dose, the OIs for the infecting serotype remained <8 for six (43%) of 14 children. In these six children, hyporesponsiveness to PCV7 was specific for the infecting serotype. Hyporesponsiveness was found for serotypes 6B (n=5) and 23F (n=1). No difference was found between the responders (n=8) and the hyporesponders (n=6) with regard to any clinical characteristics. Our data suggest that hyporesponsiveness to the infecting serotype may occur in children vaccinated with PCV7 following IPD.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Hyporesponsiveness; Invasive pneumococcal disease; Opsonophagocytic assay; Pneumococcal vaccine

Mesh:

Substances:

Year:  2014        PMID: 24486367     DOI: 10.1016/j.vaccine.2014.01.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Capsule Switching and Antimicrobial Resistance Acquired during Repeated Streptococcus pneumoniae Pneumonia Episodes.

Authors:  Bin Chang; Akiyoshi Nariai; Tsuyoshi Sekizuka; Yukihiro Akeda; Makoto Kuroda; Kazunori Oishi; Makoto Ohnishi
Journal:  J Clin Microbiol       Date:  2015-08-12       Impact factor: 5.948

2.  Global control of pneumococcal infections by pneumococcal vaccines.

Authors:  Kazunori Oishi; Kazuyo Tamura; Yukihiro Akeda
Journal:  Trop Med Health       Date:  2014-06

3.  A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease.

Authors:  Fabian Uddén; Jonas Ahl; Nils Littorin; Kristoffer Strålin; Simon Athlin; Kristian Riesbeck
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

4.  Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia.

Authors:  Diana van Kessel; Thijs Hoffman; Heleen van Velzen-Blad; Bob Meek; Suzan van Mens; Jan Grutters; Ger Rijkers
Journal:  Pneumonia (Nathan)       Date:  2017-11-05

5.  Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease.

Authors:  Helene A S Ingels; Bjørn Kantsø; Hans-Christian Slotved
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090

6.  An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination.

Authors:  Yasuhiro Tanaka; Kazuko Yamamoto; Yuichi Fukuda; Asuka Umemura; Masataka Yoshida; Shuhei Ideguchi; Nobuyuki Ashizawa; Tatsuro Hirayama; Masato Tashiro; Takahiro Takazono; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Katsunori Yanagihara; Bin Chang; Hiroshi Mukae
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters).

Authors:  Anne B Chang; Maree Toombs; Mark D Chatfield; Remai Mitchell; Siew M Fong; Michael J Binks; Heidi Smith-Vaughan; Susan J Pizzutto; Karin Lust; Peter S Morris; Julie M Marchant; Stephanie T Yerkovich; Hannah O'Farrell; Paul J Torzillo; Carolyn Maclennan; David Simon; Holger W Unger; Hasthika Ellepola; Jens Odendahl; Helen S Marshall; Geeta K Swamy; Keith Grimwood
Journal:  Front Pediatr       Date:  2022-01-17       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.